BRIACELL THERAPEUTICS CORP. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
BRIACELL THERAPEUTICS CORP. (BCTX) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $1.11 million for the 3-month period ending 2022-10-31, per its 10-Q filed 2022-12-14.
Discontinued › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2022-12-14
- BRIACELL THERAPEUTICS CORP. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2022-10-31 was $1.11M.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month |
|---|---|
| 2022-10-31 | $1.11M 10-Q · filed 2022-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |